Related Experiment Videos
[Two-stage multivariant analyses for prediction of hepatic function reserve]
1First Affiliated Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|December 1, 1994
Summary
This study identifies key liver function tests to predict outcomes in primary hepatocellular carcinoma (HCC) patients with cirrhosis. A "two-stage prediction" method accurately assesses hepatic function reserve for surgical planning.
Area of Science:
- Hepatology
- Surgical Oncology
- Biostatistics
Context:
- Primary hepatocellular carcinoma (HCC) often occurs in patients with underlying liver cirrhosis.
- Accurate preoperative assessment of hepatic function reserve is crucial for optimizing surgical outcomes in HCC patients.
- Existing methods may not fully capture the nuances of liver function relevant to surgical risk stratification.
Purpose:
- To identify significant preoperative liver function tests for predicting postoperative outcomes in HCC patients with cirrhosis.
- To develop and validate a "two-stage prediction" model using multiple regression analysis for evaluating liver function reserve.
- To enhance surgical decision-making by providing a more accurate estimation of hepatic function reserve.
Summary:
- Eleven liver function tests were evaluated in 103 HCC patients with cirrhosis.
- Six tests, including glucose tolerance ratio, total bilirubin, albumin/globulin ratio, prealbumin, prothrombin time, and indocyanine green retention, were significant predictors.
- Two multiple regression equations (Y1 and Y2) achieved predictive accuracies of 88.0% and 83.1%, respectively, forming the basis of the "two-stage prediction" method.
Impact:
- The proposed "two-stage prediction" method offers a valuable tool for selecting appropriate surgical procedures, balancing therapeutic efficacy with minimized liver damage.
- Improved preoperative risk stratification can lead to better patient management and potentially reduce postoperative complications.
- This approach aids clinicians in making informed decisions for HCC patients, particularly those with compromised liver function.